Bracanat 150mg Tablet
Price
Original price was: ₹7,453.13.₹5,963.00Current price is: ₹5,963.00.
Bracanat 150mg Tablet by Arogya delivers moderate-dose therapy for targeted disease management, ensuring reliable and effective clinical results.
Additional information
| Country of Origin | India |
|---|---|
| Manufacturer | NATCO PHARMA LTD |
| Pack Size | 30 Tablet(s) In A Bottle |
| Product Name | BRACANAT 150MG TAB |
| SKU | AROG-BRC150 |
| Salt Composition | OLAPARIB |
| Storage | Store at 20°C to 25°C |
| Strength | 150mg |
Description
Introduction
Bracanat 150mg Tablet is an anticancer medicine belonging to the class of PARP inhibitors, containing the active ingredient Olaparib. It works by blocking the PARP enzyme, which cancer cells need for DNA repair, thereby slowing down or stopping cancer cell growth. It is used in the treatment of prostate and pancreatic cancers and may be prescribed alone or in combination with other anticancer therapies based on the patient’s condition.
The dosage is determined by the healthcare provider depending on treatment response and overall health. Do not change the dose or stop the medication without medical advice. This medicine is available at certified medical stores or licensed online pharmacies with a valid prescription. Doctors may prescribe an alternative (substitute) if required due to availability or patient-specific needs.
Bracanat 150mg Tablet can slow cancer progression, improve treatment outcomes, and provide targeted therapy. Patients may compare prices and explore generic options for affordability. Always consult a healthcare professional before making any changes to treatment or medication purchase decisions.
Uses
- Prostate cancer
- Pancreatic cancer
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone experiences them. Common side effects of Bracanat 150mg Tablet include:
Common:
- Diarrhea
- Nausea and vomiting
- Loss of appetite
- Weakness
- Red or sore mouth
- Increased liver enzymes
- Itchy or cracked skin
- Dry mouth
- Red or itchy eyes
- Nail problems
- Hair loss
- Fever
- Blood in urine or burning sensation while urinating
Frequently Asked Questions (FAQ)
Q1. What is the effectiveness of Bracanat 150mg Tablet?
Bracanat 150mg Tablet and other PARP inhibitors are known to reduce cancer relapse risk significantly, particularly in ovarian cancer patients with BRCA mutation, showing around 40–70% reduction.
Q2. What type of medication is Bracanat 150mg Tablet?
It is a targeted anticancer drug classified under PARP inhibitors and is specifically used for cancers associated with BRCA gene mutations.
Q3. What is the recommended duration for taking PARP inhibitors?
The treatment duration depends on the response and clinical guidance. Some patients may take it for up to 2 years or longer as advised by their oncologist.
Q4. Is Bracanat 150mg Tablet used as a standalone treatment?
It is commonly used as maintenance therapy after platinum-based chemotherapy, but ongoing studies are exploring its standalone effectiveness in various cancers.
Q5. What are the long-term effects of Bracanat 150mg Tablet?
Long-term use may increase the risk of bone marrow disorders (like Myelodysplastic Syndrome or Acute Myeloid Leukemia), lung-related issues like pneumonitis, and blood clots (venous thromboembolism). Regular monitoring is necessary.
Disclaimer
Arogya’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Arogya. Our mission is to support, not replace, the doctor-patient relationship.
- Uncategorized
